Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics
- Liwei Li
- , Jing Li
- , May Khanna
- , Inha Jo
- , Jason P. Baird
- , Samy O. Meroueh
Research output: Contribution to journal › Article › peer-review
24
Link opens in a new tab
Scopus
citations